Verastem

(NASDAQ) VSTM

Current Price$5.85

Market Cap$522.67M

Since IPO (2012)-96%

5 Year-83%

1 Year-20%

1 Month+6%

Verastem Financials at a Glance

Market Cap

$522.67M

Revenue (TTM)

$30.91M

Net Income (TTM)

$209.47M

EPS (TTM)

$-3.33

P/E Ratio

-1.79

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$5.85

Volume

8,921

Open

$6.00

Price

$5.85

Volume

8,921

Open

$6.00

Previous Close

$5.95

Daily Range

$5.85 - $6.07

52-Week Range

$4.01 - $11.24

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$5.85

Volume

8,921

Open

$6.00

Previous Close

$5.95

Daily Range

$5.85 - $6.07

52-Week Range

$4.01 - $11.24

VSTM News

Top Drug Stocks Under $5

David HaenMar 26, 2020

Page 1

VSTM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Verastem

Industry

Biotechnology

Sector

Health Care

Employees

102

CEO

Dan Paterson

Website

www.verastem.com

Headquarters

Needham, MA 02494, US

VSTM Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

-6%

Net Income Margin

-7%

Return on Equity

-1480%

Return on Capital

-98%

Return on Assets

-85%

Earnings Yield

-55.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$522.67M

Shares Outstanding

87.84M

Volume

8.92K

Avg. Volume

1.93M

Financials (TTM)

Gross Profit

$25.62M

Operating Income

$170.13M

EBITDA

$170.13M

Operating Cash Flow

$137.51M

Capital Expenditure

$0.00

Free Cash Flow

$137.51M

Cash & ST Invst.

$204.99M

Total Debt

$76.86M

Verastem Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$17.54M

N/A

Gross Profit

$14.64M

N/A

Gross Margin

83.51%

N/A

Market Cap

$522.67M

N/A

Market Cap/Employee

$6.70M

N/A

Employees

N/A

Net Income

$32.92M

+49.0%

EBITDA

$41.18M

+34.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$117.82M

+153.0%

Accounts Receivable

$8.81M

+4306.5%

Inventory

$1.83M

N/A

Long Term Debt

$81.33M

+97.1%

Short Term Debt

$5.84M

+486.8%

Return on Assets

-85.00%

N/A

Return on Invested Capital

-97.68%

N/A

Free Cash Flow

$29.95M

-19.3%

Operating Cash Flow

$29.95M

-19.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$9.80+3.86%

RGNXREGENXBIO Inc.

RGNXREGENXBIO Inc.$9.24-1.60%

PRTAProthena Corporation plc

PRTAProthena Corporation plc$11.11+2.96%

ABSIAbsci Corporation

ABSIAbsci Corporation$5.58-0.62%

GOSSGossamer Bio, Inc.

GOSSGossamer Bio, Inc.$0.33-4.51%

VTYXVentyx Biosciences, Inc.

VTYXVentyx Biosciences, Inc.$14.00+0.00%

MLTXMoonLake Immunotherapeutics

MLTXMoonLake Immunotherapeutics$17.47-0.51%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.19+0.00%

RIGTransocean

RIGTransocean$6.48-0.06%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.77+0.01%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$8.63-0.04%

MARAMara Holdings

MARAMara Holdings$11.90+0.01%

INTCIntel

INTCIntel$108.69+0.13%

NOKNokia

NOKNokia$13.38+0.02%

Questions About VSTM

What is the current price of Verastem?

Verastem is trading at $5.85 per share.

What is the 52-week range for Verastem?

Over the past 52 weeks, Verastem has traded between $4.01 and $11.25.

How much debt does Verastem have?

As of the most recent reporting period, Verastem reported total debt of $87.17M.

How much cash does Verastem have on hand?

Verastem reported $204.99M in cash and cash equivalents in its most recent financial results.

What is Verastem’s dividend yield?

Verastem does not currently have a dividend yield.

Verastem

Verastem Financials at a Glance

VSTM News

Why Verastem Stock Spiked Today

Why Verastem Stock Is Crushing It Today

Why Verastem Stock Sank Today

Why Verastem Stock Jumped Briefly This Morning

Why Verastem Stock Is Rising Today

Here's Why Verastem Oncology Is Tanking Today

3 Top Stocks Under $5 to Buy Now

Top Drug Stocks Under $5

VSTM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Verastem

VSTM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Verastem Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VSTM

What is the current price of Verastem?

What is the 52-week range for Verastem?

How much debt does Verastem have?

How much cash does Verastem have on hand?

What is Verastem’s dividend yield?

Premium Investing Services